Top Markets
#1 Islamic Coin Islamic Coin +151.49%
#2 DOVU DOVU +48.08%
#3 Akedo Akedo +40.50%
#4 Velvet Velvet +35.26%
#5 Black Phoenix Black Phoenix +34.23%
#6 Cross Cross +19.18%
#7 DoubleZero DoubleZero +18.36%
#8 Tutorial Tutorial +15.48%
#9 Cap Cap +14.84%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +10.23%
Coin of the day
Islamic Coin Islamic Coin
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.

PHAXIAM Therapeutics S.A.

PHXM
Rankning i aktier #39465
PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating... PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating therapies for drug-resistant bacterial infections, operating in both France and the U.S. The company's pipeline includes eryaspase, currently undergoing Phase 3 clinical trials for advanced pancreatic cancer and Phase 2 studies for treating triple-negative breast cancer and acute lymphoblastic leukemia after initial treatments. Additionally, PHAXIAM is advancing a range of phage therapies designed to combat hazardous, drug-resistant bacteria. These pathogens, such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, are responsible for over two-thirds of all resistant infections acquired in hospital settings. Established in 2004, the company was previously known as ERYTECH Pharma S.A. before adopting the name PHAXIAM Therapeutics S.A. in June 2023. Its corporate headquarters are located in Lyon, France.
Aktiekurs
$0.11725176
Senast synkroniserad: 2025-07-14
Marknadsvärde
$481.50K
Förändring (1 dag)
-0.20%
Förändring (1 år)
0.00%
Land
FR
Handel PHAXIAM Therapeutics S.A. (PHXM)

Kategori

Healthcare
EPS för PHAXIAM Therapeutics S.A. (PHXM)
EPS per June 2024 TTM: $-4.23
Enligt PHAXIAM Therapeutics S.A.s senaste finansiella rapporter och aktiekurs är bolagets nuvarande EPS (TTM) $-4.23. Vid slutet av 2022 hade bolaget ett EPS på $-0.07, en minskning jämfört med EPS från 2021 som var $-23.87.
EPS-historik för PHAXIAM Therapeutics S.A. från 2016 till 2026
EPS vid slutet av varje år
År EPS Ändra
2026 (TTM) $-4.23 -23.50%
2023 $-5.53 7,492.45%
2022 $-0.07 -99.69%
2021 $-23.87 -46.82%
2020 $-44.88 23.87%
2019 $-36.23 60.03%
2018 $-22.64 -30.76%
2017 $-32.70 21.96%
2016 $-26.81 0.00%
EPS för liknande företag eller konkurrenter
Företag EPS EPS-differens Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -509.44%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -755.76%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -423.86%
BE